Tenoclax® Venetoclax Product Information Proprietary Name: Tenoclax® Generic Name: Venetoclax Dosage Form: Film-coated Tablet Strengths: 10 mg, 50 mg, 100 mg Indications: Chronic lymphocytic leukemia (CLL), and Acute myeloid leukemia (AML) Download Leaflet Oncology Tenoclax® Venetoclax is indicated for the treatment of chronic lymphocytic leukemia (CLL), and acute myeloid leukemia (AML).

M 001 3 M 001 4 M 001 6 M 008 M 009 M 010 M 011

Adriax® Doxorubicin hydrochloride Product Information Proprietary Name: Adriax® Generic Name: Doxorubicin hydrochloride Dosage Form: Vial Strengths: 10 mg/5 ml, 50 mg/25 ml Indications: Breast and Lungs cancer, Malignant Lymphomas and Leukemia Download Leaflet Oncology Adriax® Doxorubicin hydrochloride is indicated for the treatment of breast and lungs cancer, malignant lymphomas and leukemia.

Trexoma 2.5® Methotrexate Product Information Proprietary Name: Trexoma® Generic Name: Methotrexate Dosage Form: Tablet Strengths: 2.5 mg Indications: Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriasis Download Leaflet Rheumatology Trexoma® Methotrexate is indicated for the treatment of rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, and psoriasis.

Ciplona® Cisplatin Product Information Proprietary Name: Ciplona® Generic Name: Cisplatin Dosage Form: Vial Strengths: 10 mg/10 ml, 50 mg/50 ml Indications: Cancers such as testicular, ovary, tumor of bladder, head and neck epithelioma, small cell lung and advanced non-small cell lung cancer and for cervical cancer in combination with radiotherapy Download Leaflet Oncology Ciplona® Cisplatin is indicated for the treatment of cancers such as testicular, ovary, tumor of bladder, head and neck epithelioma, small cell lung and advanced...

Xolitop® Ruxolitinib Product Information Proprietary Name: Xolitop® Generic Name: Ruxolitinib Dosage Form: Topical Cream Strengths: 1.5 g/100 g Indications: Non-segmental vitiligo with facial involvement, Mild to moderate atopic dermatitis (eczema) Download Leaflet Other Products Xolitop® Ruxolitinib is indicated for the treatment of non-segmental vitiligo with facial involvement, and mild to moderate atopic dermatitis (eczema).

Atranel® Nelarabine Product Information Proprietary Name: Atranel® Generic Name: Nelarabine Dosage Form: Vial Strengths: 250 mg/ 50 ml Indications: T-cell acute lymphoblastic leukemia, T-cell lymphoblastic lymphoma Download Leaflet Oncology Atranel® Nelarabine is indicated for the treatment of T-cell acute lymphoblastic leukemia, T-cell lymphoblastic lymphoma.

Tedanix® Nintedanib Product Information Proprietary Name: Tedanix® Generic Name: Nintedanib Dosage Form: Soft Gelatin Capsule Strengths: 100 mg, 150 mg Indications: Idiopathic pulmonary fibrosis (IPF), other chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype, systemic sclerosis associated interstitial lung disease (SSc-ILD) Download Leaflet Other Products Tedanix® Nintedanib is indicated for the treatment of idiopathic pulmonary fibrosis (IPF), other chronic fibrosing interstitial lung diseases (ILDs) with...

Etoraz® Etoposide Product Information Proprietary Name: Etoraz® Generic Name: Etoposide Dosage Form: Vial Strengths: 100 mg/5 ml, 200 mg/10 ml Indications: Cancers such as testicular cancer, Small-cell lung cancer, Blood cancer, Tumor in the lymphatic system and reproductive system cancers Download Leaflet Oncology Etoraz® Etoposide is indicated for the treatment of cancers such as testicular cancer, small-cell lung cancer, blood cancer, tumor in the lymphatic system and reproductive system cancers.